OptiBiotix Health (OPTI) Competitors GBX 11.98 +0.73 (+6.44%) As of 11:42 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock OPTI vs. PHE, CYAN, OKYO, IGAS, ALT, CRDL, REVB, IDP, BON, and BSFAShould you be buying OptiBiotix Health stock or one of its competitors? The main competitors of OptiBiotix Health include PowerHouse Energy Group (PHE), CyanConnode (CYAN), OKYO Pharma (OKYO), IGas Energy (IGAS), Altitude Group (ALT), Cordel Group (CRDL), Revolution Beauty Group (REVB), InnovaDerma (IDP), Bonmarche (BON), and BSF Enterprise (BSFA). These companies are all part of the "pharmaceutical products" industry. OptiBiotix Health vs. Its Competitors PowerHouse Energy Group CyanConnode OKYO Pharma IGas Energy Altitude Group Cordel Group Revolution Beauty Group InnovaDerma Bonmarche BSF Enterprise OptiBiotix Health (LON:OPTI) and PowerHouse Energy Group (LON:PHE) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk. Does the media refer more to OPTI or PHE? In the previous week, OptiBiotix Health's average media sentiment score of 0.00 equaled PowerHouse Energy Group'saverage media sentiment score. Company Overall Sentiment OptiBiotix Health Neutral PowerHouse Energy Group Neutral Which has more volatility and risk, OPTI or PHE? OptiBiotix Health has a beta of 1.71, indicating that its stock price is 71% more volatile than the S&P 500. Comparatively, PowerHouse Energy Group has a beta of 2.63, indicating that its stock price is 163% more volatile than the S&P 500. Is OPTI or PHE more profitable? PowerHouse Energy Group has a net margin of -356.56% compared to OptiBiotix Health's net margin of -524.43%. PowerHouse Energy Group's return on equity of -25.34% beat OptiBiotix Health's return on equity.Company Net Margins Return on Equity Return on Assets OptiBiotix Health-524.43% -36.76% -13.93% PowerHouse Energy Group -356.56%-25.34%-17.45% Which has higher earnings & valuation, OPTI or PHE? PowerHouse Energy Group has higher revenue and earnings than OptiBiotix Health. PowerHouse Energy Group is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOptiBiotix Health£590.01K19.88-£3.09M-£3.16-3.79PowerHouse Energy Group£623.95K50.02-£2.22M-£0.04-15.34 Do insiders & institutionals have more ownership in OPTI or PHE? 4.9% of OptiBiotix Health shares are owned by institutional investors. Comparatively, 3.4% of PowerHouse Energy Group shares are owned by institutional investors. 12.0% of OptiBiotix Health shares are owned by company insiders. Comparatively, 25.2% of PowerHouse Energy Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryPowerHouse Energy Group beats OptiBiotix Health on 8 of the 11 factors compared between the two stocks. Get OptiBiotix Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OPTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPTI vs. The Competition Export to ExcelMetricOptiBiotix HealthBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£11.73M£138.55M£5.67B£3.09BDividend YieldN/A3.74%3.79%5.04%P/E Ratio-3.793.8230.58174.56Price / Sales19.884,361.81463.91282,771.09Price / Cash8.6813.1937.4027.94Price / Book1.5444.949.095.38Net Income-£3.09M-£90.99M£3.25B£5.89B7 Day Performance14.05%1.62%4.76%-0.04%1 Month Performance1.72%5.18%6.72%0.72%1 Year Performance-53.25%184.04%30.51%64.34% OptiBiotix Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPTIOptiBiotix HealthN/AGBX 11.98+6.4%N/A-56.7%£11.73M£590.01K-3.791News CoverageGap UpPHEPowerHouse Energy GroupN/AGBX 0.66-4.3%N/A-46.2%£30.30M£623.95K-14.894Positive NewsGap UpCYANCyanConnodeN/AGBX 7.93+2.3%N/A-1.2%£27.71M£23.07M-5.91100Positive NewsOKYOOKYO PharmaN/AN/AN/AN/A£23.24MN/A-140.007Gap DownIGASIGas EnergyN/AN/AN/AN/A£18.97M£59.17M-148.90100Gap UpALTAltitude GroupN/AGBX 19.85-0.8%N/A-39.3%£14.44M£23.50M21.2450CRDLCordel GroupN/AGBX 6.06-6.8%N/A+24.1%£13.14M£4.83M-9.3035Gap DownREVBRevolution Beauty GroupN/AGBX 3.90+20.0%N/A-80.6%£12.47M£173.87M-22.7310Gap UpIDPInnovaDermaN/AN/AN/AN/A£8.14M£9.82M-3.878,720BONBonmarcheN/AN/AN/AN/A£4.25M£186.15M0.91100BSFABSF EnterpriseN/AGBX 2.08+2.5%N/A-48.8%£2.56M£80.25K-1.2512Gap Down Related Companies and Tools Related Companies PowerHouse Energy Group Alternatives CyanConnode Alternatives OKYO Pharma Alternatives IGas Energy Alternatives Altitude Group Alternatives Cordel Group Alternatives Revolution Beauty Group Alternatives InnovaDerma Alternatives Bonmarche Alternatives BSF Enterprise Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:OPTI) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiBiotix Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share OptiBiotix Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access